AA
WST icon

Addison Advisors’s West Pharmaceutical WST Stock Holding History

Addison Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28K Sell
78
-23
-23% -$7.03K 0.01% 304
2026
Q1 		$25.3K Sell
101
-10
-9% -$2.49K 0.01% 523
2025
Q4 		$30.5K Hold
111
– – 0.01% 492
2025
Q3 		$29.1K Hold
111
– – 0.01% 494
2025
Q2 		$24.3K Buy
111
+24
+28% +$5.13K 0.01% 511
2025
Q1 		$19.5K Sell
87
-9
-9% -$2.48K 0.01% 507
2024
Q4 		$31.4K Buy
96
+8
+9% +$2.52K 0.01% 444
2024
Q3 		$26.4K Sell
88
-5
-5% -$1.53K 0.01% 472
2024
Q2 		$30.6K Buy
93
+4
+4% +$1.41K 0.01% 427
2024
Q1 		$35.2K Sell
89
-94
-51% -$34.8K 0.01% 401
2023
Q4 		$64.4K Buy
183
+41
+29% +$14.5K 0.03% 326
2023
Q3 		$53.3K Buy
142
+39
+38% +$15.1K 0.02% 315
2023
Q2 		$39.4K Buy
103
+12
+13% +$4.29K 0.02% 347
2023
Q1 		$31.5K Buy
91
+8
+10% +$2.34K 0.02% 350
2022
Q4 		$19.5K Buy
83
+41
+98% +$9.72K 0.01% 380
2022
Q3 		$10K Sell
42
-1
-2% -$305 0.01% 452
2022
Q2 		$13K Sell
43
-31
-42% -$10.1K 0.01% 416
2022
Q1 		$30K Buy
74
+51
+222% +$20K 0.02% 352
2021
Q4 		$11K Buy
23
+19
+475% +$8.18K 0.01% 399
2021
Q3 		$2K Buy
+4
New +$1.69K ﹤0.01% 391

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Addison Advisors's WST Position: Q2 2026 in Review

Addison Advisors reduced its West Pharmaceutical (WST) stake by 23% in Q2 2026, selling an estimated $7.03K and leaving 78 shares worth $28K. The position accounts for 0.01% of the portfolio, ranked #304.

Addison Advisors first reported a position in WST in Q3 2021 and has held it in 20 quarters since. The position peaked at $64.4K in Q4 2023. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Addison Advisors held 78 shares of West Pharmaceutical worth $28K as of Q2 2026.
  • Addison Advisors sold 23 West Pharmaceutical shares in Q2 2026, an estimated $7.03K.
  • West Pharmaceutical made up 0.01% of Addison Advisors's portfolio in Q2 2026, its #304 holding.
  • Addison Advisors first reported a position in West Pharmaceutical in Q3 2021 and has held it in 20 quarters since.
  • Addison Advisors's West Pharmaceutical position peaked at $64.4K in Q4 2023.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Addison Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.